Belldegrun A - Search Results

1

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer.

Belldegrun A, Webb DE, Austin HA 3rd, Steinberg SM, White DE, Linehan WM, Rosenberg SA. Belldegrun A, et al. Ann Intern Med. 1987 Jun;106(6):817-22. doi: 10.7326/0003-4819-106-6-817. Ann Intern Med. 1987. PMID: 3495213

2

Renal toxicity of interleukin-2 administration in patients with metastatic renal cell cancer: effect of pre-therapy nephrectomy.

Belldegrun A, Webb DE, Austin HA 3rd, Steinberg SM, Linehan WM, Rosenberg SA. Belldegrun A, et al. J Urol. 1989 Mar;141(3):499-503. doi: 10.1016/s0022-5347(17)40872-x. J Urol. 1989. PMID: 2783983

3

Metabolic and renal effects of interleukin-2 immunotherapy for metastatic cancer.

Webb DE, Austin HA 3rd, Belldegrun A, Vaughan E, Linehan WM, Rosenberg SA. Webb DE, et al. Among authors: belldegrun a. Clin Nephrol. 1988 Sep;30(3):141-5. Clin Nephrol. 1988. PMID: 3263237

4

Anti-tumor reactivity of human lymphokine activated killer (LAK) cells against fresh and cultured preparations of renal cell cancer.

Belldegrun A, Uppenkamp I, Rosenberg SA. Belldegrun A, et al. J Urol. 1988 Jan;139(1):150-5. doi: 10.1016/s0022-5347(17)42342-1. J Urol. 1988. PMID: 3257274

5

Adoptive immunotherapy of urologic tumors.

Belldegrun A, Rosenberg SA. Belldegrun A, et al. Cancer Treat Res. 1989;46:213-33. doi: 10.1007/978-1-4613-1595-7_12. Cancer Treat Res. 1989. PMID: 2577191 Review. No abstract available.

6

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.

Belldegrun A, Muul LM, Rosenberg SA. Belldegrun A, et al. Cancer Res. 1988 Jan 1;48(1):206-14. Cancer Res. 1988. PMID: 3257161

7

Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.

Belldegrun A, Kasid A, Uppenkamp M, Topalian SL, Rosenberg SA. Belldegrun A, et al. J Immunol. 1989 Jun 15;142(12):4520-6. J Immunol. 1989. PMID: 2723437

8

Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Belldegrun A, Kasid A, Uppenkamp M, Rosenberg SA. Belldegrun A, et al. Cancer Immunol Immunother. 1990;31(1):1-10. doi: 10.1007/BF01742489. Cancer Immunol Immunother. 1990. PMID: 1968360 Free PMC article.

9

Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma.

Sargent ER, Gomella LG, Belldegrun A, Linehan WM, Kasid A. Sargent ER, et al. Among authors: belldegrun a. J Urol. 1989 Nov;142(5):1364-8. doi: 10.1016/s0022-5347(17)39100-0. J Urol. 1989. PMID: 2810532

10

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.

Stötter H, Wiebke EA, Tomita S, Belldegrun A, Topalian S, Rosenberg SA, Lotze MT. Stötter H, et al. Among authors: belldegrun a. J Immunol. 1989 Mar 1;142(5):1767-73. J Immunol. 1989. PMID: 2493053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters